141 related articles for article (PubMed ID: 35344190)
1. Lipocalin2 as a potential antibacterial drug against Acinetobacter baumannii infection.
Lim D; Park SJ; Kim HY; Shin M; Song M
J Microbiol; 2022 Apr; 60(4):444-449. PubMed ID: 35344190
[TBL] [Abstract][Full Text] [Related]
2. Lipocalin-2 is an essential component of the innate immune response to Acinetobacter baumannii infection.
Sheldon JR; Himmel LE; Kunkle DE; Monteith AJ; Maloney KN; Skaar EP
PLoS Pathog; 2022 Sep; 18(9):e1010809. PubMed ID: 36054235
[TBL] [Abstract][Full Text] [Related]
3. In vivo antibacterial activity of Zataria multiflora Boiss extract and its components, carvacrol, and thymol, against colistin-resistant Acinetobacter baumannii in a pneumonic BALB/c mouse model.
Hassannejad N; Bahador A; Rudbari NH; Modarressi MH; Parivar K
J Cell Biochem; 2019 Nov; 120(11):18640-18649. PubMed ID: 31338900
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic effect of phages on extensively drug-resistant Acinetobacter baumannii-induced sepsis in mice].
Deng LY; Yang ZC; Gong YL; Huang GT; Yin SP; Jiang B; Peng YZ
Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):523-8. PubMed ID: 27647067
[TBL] [Abstract][Full Text] [Related]
5. Contribution of Active Iron Uptake to Acinetobacter baumannii Pathogenicity.
Runci F; Gentile V; Frangipani E; Rampioni G; Leoni L; Lucidi M; Visaggio D; Harris G; Chen W; Stahl J; Averhoff B; Visca P
Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30718286
[No Abstract] [Full Text] [Related]
6. Octopromycin: Antibacterial and antibiofilm functions of a novel peptide derived from Octopus minor against multidrug-resistant Acinetobacter baumannii.
Rajapaksha DC; Jayathilaka EHTT; Edirisinghe SL; Nikapitiya C; Lee J; Whang I; De Zoysa M
Fish Shellfish Immunol; 2021 Oct; 117():82-94. PubMed ID: 34311097
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Acinetobacter infections.
Michalopoulos A; Falagas ME
Expert Opin Pharmacother; 2010 Apr; 11(5):779-88. PubMed ID: 20210684
[TBL] [Abstract][Full Text] [Related]
8. Piscidin is highly active against carbapenem-resistant Acinetobacter baumannii and NDM-1-producing Klebsiella pneumonia in a systemic Septicaemia infection mouse model.
Pan CY; Chen JC; Chen TL; Wu JL; Hui CF; Chen JY
Mar Drugs; 2015 Apr; 13(4):2287-305. PubMed ID: 25874924
[TBL] [Abstract][Full Text] [Related]
9. A Simplified Derivative of Human Defensin 5 with Potent and Efficient Activity against Multidrug-Resistant Acinetobacter baumannii.
Wang C; Zhao G; Wang S; Chen Y; Gong Y; Chen S; Xu Y; Hu M; Wang X; Zeng H; Wang A; Liu D; Su Y; Cheng T; Chen F; Wang J
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158275
[TBL] [Abstract][Full Text] [Related]
10. Cationic amphiphilic alpha-helical peptides for the treatment of carbapenem-resistant Acinetobacter baumannii infection.
Huang Y; Wiradharma N; Xu K; Ji Z; Bi S; Li L; Yang YY; Fan W
Biomaterials; 2012 Dec; 33(34):8841-7. PubMed ID: 22925814
[TBL] [Abstract][Full Text] [Related]
11. Depletion of Alveolar Macrophages Increases Pulmonary Neutrophil Infiltration, Tissue Damage, and Sepsis in a Murine Model of Acinetobacter baumannii Pneumonia.
Lee HH; Aslanyan L; Vidyasagar A; Brennan MB; Tauber MS; Carrillo-Sepulveda MA; Dores MR; Rigel NW; Martinez LR
Infect Immun; 2020 Jun; 88(7):. PubMed ID: 32366576
[No Abstract] [Full Text] [Related]
12. Efficacy of bacteriophage treatment against carbapenem-resistant Acinetobacter baumannii in Galleria mellonella larvae and a mouse model of acute pneumonia.
Jeon J; Park JH; Yong D
BMC Microbiol; 2019 Apr; 19(1):70. PubMed ID: 30940074
[TBL] [Abstract][Full Text] [Related]
13. Copper Resistance of the Emerging Pathogen Acinetobacter baumannii.
Williams CL; Neu HM; Gilbreath JJ; Michel SL; Zurawski DV; Merrell DS
Appl Environ Microbiol; 2016 Oct; 82(20):6174-6188. PubMed ID: 27520808
[TBL] [Abstract][Full Text] [Related]
14. Aging exacerbates mortality of
Gu H; Liu D; Zeng X; Peng LS; Yuan Y; Chen ZF; Zou QM; Shi Y
Aging (Albany NY); 2018 Jul; 10(7):1597-1608. PubMed ID: 30018181
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis.
Nielsen TB; Pantapalangkoor P; Luna BM; Bruhn KW; Yan J; Dekitani K; Hsieh S; Yeshoua B; Pascual B; Vinogradov E; Hujer KM; Domitrovic TN; Bonomo RA; Russo TA; Lesczcyniecka M; Schneider T; Spellberg B
J Infect Dis; 2017 Aug; 216(4):489-501. PubMed ID: 28931235
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Immune Responses in
Sato Y; Tansho-Nagakawa S; Ubagai T; Ono Y
Front Immunol; 2020; 11():601614. PubMed ID: 33329595
[No Abstract] [Full Text] [Related]
17. IL-10 Protects Mice From the Lung Infection of
Kang MJ; Jang AR; Park JY; Ahn JH; Lee TS; Kim DY; Lee MS; Hwang S; Jeong YJ; Park JH
Front Immunol; 2020; 11():270. PubMed ID: 32153580
[TBL] [Abstract][Full Text] [Related]
18. Intranasal treatment with bacteriophage rescues mice from Acinetobacter baumannii-mediated pneumonia.
Wang Y; Mi Z; Niu W; An X; Yuan X; Liu H; Li P; Liu Y; Feng Y; Huang Y; Zhang X; Zhang Z; Fan H; Peng F; Tong Y; Bai C
Future Microbiol; 2016 May; 11():631-41. PubMed ID: 26925593
[TBL] [Abstract][Full Text] [Related]
19. Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates.
Trebosc V; Gartenmann S; Tötzl M; Lucchini V; Schellhorn B; Pieren M; Lociuro S; Gitzinger M; Tigges M; Bumann D; Kemmer C
mBio; 2019 Jul; 10(4):. PubMed ID: 31311879
[TBL] [Abstract][Full Text] [Related]
20. Diabetic murine models for Acinetobacter baumannii infection.
Luo G; Spellberg B; Gebremariam T; Bolaris M; Lee H; Fu Y; French SW; Ibrahim AS
J Antimicrob Chemother; 2012 Jun; 67(6):1439-45. PubMed ID: 22389456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
